医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Mental/behavioral disorder due to acute hallucinogen intoxication (F16.000) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological
Ketamine-induced mental/behavioral disorder (F15.900x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is be
Amphetamine-stimulant-induced mental/behavioral disorder (F15.900x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological intro
Caffeine-induced mental/behavioral disorder (F15.900x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is be
Caffeine-containing stimulant-induced mental/behavioral disorder (F15.900x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathologic
Mental/behavioral disorder due to other stimulant (incl. caffeine) use (F15.900) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed patholog
Other mental/behavioral disorders due to other stimulant (incl. caffeine) use (F15.800) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed p
Ketamine-induced residual/late-onset psychotic disorder (F15.700x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introd
Amphetamine-stimulant-induced residual/late-onset psychotic disorder (F15.700x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathol
Caffeine-induced residual/late-onset psychotic disorder (F15.700x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introd
Caffeine-containing stimulant-induced residual/late-onset psychotic disorder (F15.700x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detaile
Residual/late-onset psychotic disorder due to other stimulant (incl. caffeine) use (F15.700) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detai
Ketamine-induced amnestic syndrome (F15.600x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compi
Amphetamine-stimulant-induced amnestic syndrome (F15.600x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction i
Caffeine-induced amnestic syndrome (F15.600x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compi
Caffeine-containing stimulant-induced amnestic syndrome (F15.600x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introd
Amnestic syndrome due to other stimulant (incl. caffeine) use (F15.600) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological intr
Amphetamine-toxic psychosis (F15.501) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Ketamine-induced psychotic disorder (F15.500x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being comp
Amphetamine-stimulant-induced psychotic disorder (F15.500x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction
|
